Recent Highlights
- Up 7.5p to £11.81 after its second quarter earnings were in line ... Apple results and bid hopes lift FTSE for first time in six days Leading shares are heading for their first rise after five days of decline, and in some style. Good results from Apple, takeovers real and rumoured, and signs from the Bank ... The Guardian - business - 1 week, 3 days ago
- On Tuesday it had agreed to settle certain U.S. lawsuits alleging its ... Glaxo says settles some Paxil birth-defect cases GlaxoSmithKline said on Tuesday it had agreed to settle certain U.S. lawsuits alleging its Paxil antidepressant caused birth defects in some patients but declined to put a figure on the ... RecentNews.co.uk - 1 week, 4 days ago
- Taking a £1.57bn charge to cover legal costs and settlements over two ... Glaxo takes £1.57bn legal charge Charge covers costs and settlements over GlaxoSmithKline's Avandia and Paxil drugs, and closure of factory in Puerto Rico GlaxoSmithKline is taking a £1.57bn charge to cover legal costs and settlements ... The Guardian - business - 2 weeks, 2 days ago
- Climbed 7p to 1188.5p as US regulators agreed its Avandia diabetes drug ... FTSE falls on US and China slowdown but Experian shines Everyone was expecting it, but that hasn't stopped the market reacting gloomily to renewed signs of a global slowdown. Last night the US Federal Reserve cut its GDP forecast for ... The Guardian - business - 2 weeks, 2 days ago
Latest Articles
1 month ago
Who will pay to end meningitis deaths?
A new, cheap meningitis vaccine has been approved by the World Health Organisation and will be rolled out in the three worst-affected countries of the African meningitis belt in the ...
The Guardian - business - 6:48 p.m. Thursday 1st July 2010 BST
View Article
Related Articles
Email to Friend
1 month, 1 week ago
Report Identifies FDA's Weaknesses In Monitoring Foreign Drug Trials
The FDA inspected 0.7 percent of foreign clinical drug trial sites in 2008 while 80 percent of applications approved for marketing that year contained data from foreign drug trials, according ...
Medical News Today - 1 p.m. Thursday 24th June 2010 BST
View Article
Related Articles
Email to Friend
1 month, 2 weeks ago
Pfizer Joins Open-Access Medicinal Chemistry Public-Private Collaboration
The Structural Genomics Consortium (SGC) and Pfizer have announced that Pfizer will join the SGC-led public-private collaboration to generate small molecule inhibitors - "chemical probes" - for proteins involved in ...
Medical News Today - 8 a.m. Saturday 12th June 2010 BST
View Article
Related Articles
Email to Friend
2 months, 1 week ago
Abbott buys Piramal unit to become number one in India
Despite rumours of Pfizer, Sanofi or GlaxoSmithKline buying the domestic drug-making business of India’s Piramal Healthcare, it is Abbott that has come up on the blind side and won the ...
PharmaTimes - 1 a.m. Monday 24th May 2010 BST
View Article
Related Articles
Email to Friend
2 months, 2 weeks ago
Pharmaceutical Companies Provide EPA 100 Drugs To Help Predict Toxicity
The U.S. Environmental Protection Agency will continue validating its ToxCast screening tool by screening more than 100 drugs provided by Pfizer, GlaxoSmithKline, Sanofi-Aventis, and Merck. These drugs never entered the ...
Medical News Today - 8 a.m. Saturday 15th May 2010 BST
View Article
Related Articles
Email to Friend
2 months, 2 weeks ago
GlaxoSmithKline may act on vaccine delay
Giant pharma company GlaxoSmithKline is having high-level internal discussions as a result of the story on this blog two days ago, which pointed out that babies in most of Africa ...
The Guardian - business - 12:04 p.m. Thursday 13th May 2010 BST
View Article
Related Articles
Email to Friend
2 months, 3 weeks ago
GSK vaccine to save lives - but not quite yet
In March, the giant pharma company GlaxoSmithKline announced it would be supplying 30 million doses of life-saving pneumococcal vaccine to the developing world - but the cost is high and ...
The Guardian - business - 6:38 p.m. Tuesday 11th May 2010 BST
View Article
Related Articles
Email to Friend
4 months, 1 week ago
GlaxoSmithKline, Pfizer Will Supply 600M Doses Of Reduced-Price Pneumococcal Vaccines To Developing Countries Over 10 Years, GAVI Says
The GAVI Alliance on Tuesday formally announced that drugmakers GlaxoSmithKline and Pfizer had signed off on a "10-year deal ... to supply 60 million doses a year of cut-price pneumococcal ...
Medical News Today - 11 a.m. Thursday 25th March 2010 GMT
View Article
Related Articles
Email to Friend
Providing Long-Term Affordable Supply Of Pneumococcal Vaccines To The World's Poorest Children
Millions of infants and young children in the world's poorest countries will receive potentially life-saving vaccines that help protect against pneumococcal disease, including pneumonia - the world's biggest childhood killer, ...
Medical News Today - 7 a.m. Thursday 25th March 2010 GMT
View Article
Related Articles
Email to Friend
4 months, 1 week ago
GSK and Pfizer pledge vaccines
GlaxoSmithKline and Pfizer could share up to $1.5bn from deeply discounted sales of their pneumococcal vaccines to the world's poorest countries as part of a pioneering project
Financial Times - UK equities - 1:10 a.m. Wednesday 24th March 2010 GMT
View Article
Related Articles
Email to Friend

